share_log
Benzinga ·  10/09 08:07

Windtree Therapeutics Shares Are Trading Higher After the Company Announced That the Trial Design of Its SEISMiC Phase 2b Has Been Published by the European Society of Cardiology Heart Failure

windtree therapeutics股價上漲,因該公司宣佈其SEISMiC第20億階段的試驗方案已被歐洲心臟病學會心力衰竭分會發布

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論